Skip to main content
ALMR logo

Alamar Biosciences, Inc.

ALMRNASDAQHealthcareMedical Instruments & Supplies

$30.39Today:- (-)

As of Oct 26, 2026 close

Market cap
$1.78B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$18.85$39.61
Volume (live)
-
Avg. volume (3M)
742.78K

Alamar Biosciences (ALMR) Income Statement

Alamar Biosciences reported revenue of $74.21M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 195.2% from $25.14M a year earlier. Alamar Biosciences posted a net loss of $29.82M, compared with a net loss of $47.07M a year earlier. Gross margin was 56.2% and operating margin -42.2%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $29.43M, up 82.1% from the same quarter a year earlier.

Alamar Biosciences Income Statement Analysis

Values in millions USD

Scroll to see more
Alamar Biosciences, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024
Period endingDec 2025Dec 2024
Revenue & Gross Profit
Revenue74.2125.14
Cost of Revenue32.5116.54
Gross Profit41.718.61
Operating Expenses
Research & Development37.4739.23
Selling, General & Administrative35.5718.94
Operating Expenses73.0458.18
Operating Income-31.33-49.57
Other Income/Expense
Interest Income2.164.68
Interest Expense-0.402.08
Other Income/Expense2.18-0.09
Income
Income Before Tax-29.15-47.06
Income Tax Expense0.670.01
Net Income-29.82-47.07
Net Income - Continuous Operations-29.82-47.07
Net Income - Discontinued Operations--
EBITDA-28.57-41.79
EBIT-31.33-44.98
Depreciation & Amortization2.763.19
Earnings Per Share
Basic EPS-3.00-1.00
Diluted EPS-3.00-1.00
Basic Shares Outstanding11.5566.52
Diluted Shares Outstanding11.5566.52

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Alamar Biosciences Financial Statements

What was Alamar Biosciences's revenue in fiscal 2025?

Alamar Biosciences reported revenue of $74.21M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 195.2% from $25.14M a year earlier.

Is Alamar Biosciences profitable?

No. Alamar Biosciences reported a net loss of $29.82M in fiscal 2025. In fiscal 2024 it lost $47.07M.

What is Alamar Biosciences's operating margin?

Alamar Biosciences's operating income was −$31.33M on revenue of $74.21M in fiscal 2025, an operating margin of -42.2%, compared with -197.2% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition